Sign in

CIK 0001710072 · Large accelerated filer

Edgewise Therapeutics, Inc.

Sign in to watch
Ticker
EWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
821725586
Phone
720-262-7002
Business address
1715 38TH ST, BOULDER, CO, 80301
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. 4 Derivatives Options or other derivatives
  5. 8-K/A Event Exhibits
  6. 8-K Event Acquisition or sale completed · Regulation FD disclosure
  7. 4 Planned sale Chief Scientific Officer sold 200,000 shares at an average $39.41 ($7,881,402)
  8. 4 Grant or award Director acquired 319 shares (grant or award)
  9. 144 Insider Sale of Securities
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 8-K Event Shareholder vote results
  17. 8-K Event Material agreement
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. 8-K Event Results of operations

Page 2 of 22 · 423 filings